Royal Bank of Canada’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-40,728
| Closed | -$45K | – | 7296 |
|
|
2025
Q2 | $45K | Buy |
40,728
+38,417
| +1,662% | +$46.9K | ﹤0.01% | 5970 |
|
|
2025
Q1 | $2K | Sell |
2,311
-17,738
| -88% | -$33K | ﹤0.01% | 6569 |
|
|
2024
Q4 | $123K | Sell |
20,049
-22,029
| -52% | -$262K | ﹤0.01% | 5204 |
|
|
2024
Q3 | $696K | Buy |
42,078
+19,738
| +88% | +$216K | ﹤0.01% | 3838 |
|
|
2024
Q2 | $154K | Buy |
22,340
+22,038
| +7,297% | +$189K | ﹤0.01% | 4969 |
|
|
2024
Q1 | $3K | Sell |
302
-5,411
| -95% | -$62.7K | ﹤0.01% | 6594 |
|
|
2023
Q4 | $48K | Sell |
5,713
-490
| -8% | -$2.85K | ﹤0.01% | 6009 |
|
|
2023
Q3 | $52K | Buy |
6,203
+758
| +14% | +$6.43K | ﹤0.01% | 5760 |
|
|
2023
Q2 | $50K | Buy |
5,445
+553
| +11% | +$6.2K | ﹤0.01% | 5780 |
|
|
2023
Q1 | $67K | Sell |
4,892
-503
| -9% | -$10.4K | ﹤0.01% | 5461 |
|
|
2022
Q4 | $91K | Buy |
5,395
+1,066
| +25% | +$21.3K | ﹤0.01% | 5520 |
|
|
2022
Q3 | $99K | Buy |
4,329
+2,272
| +110% | +$45.9K | ﹤0.01% | 5309 |
|
|
2022
Q2 | $37K | Sell |
2,057
-446
| -18% | -$7.95K | ﹤0.01% | 5852 |
|
|
2022
Q1 | $66K | Sell |
2,503
-1,148
| -31% | -$21.4K | ﹤0.01% | 5912 |
|
|
2021
Q4 | $107K | Sell |
3,651
-25,093
| -87% | -$1.25M | ﹤0.01% | 5881 |
|
|
2021
Q3 | $1.89M | Buy |
28,744
+123
| +0.4% | +$9.41K | ﹤0.01% | 3116 |
|
|
2021
Q2 | $2.38M | Buy |
28,621
+5,392
| +23% | +$399K | ﹤0.01% | 2907 |
|
|
2021
Q1 | $1.78M | Buy |
23,229
+21,214
| +1,053% | +$1.93M | ﹤0.01% | 3105 |
|
|
2020
Q4 | $178K | Buy |
2,015
+3
| +0.1% | +$211 | ﹤0.01% | 4939 |
|
|
2020
Q3 | $149K | Hold |
2,012
| – | – | ﹤0.01% | 4732 |
|
|
2020
Q2 | $147K | Sell |
2,012
-367
| -15% | -$22.3K | ﹤0.01% | 4622 |
|
|
2020
Q1 | $133K | Buy |
2,379
+43
| +2% | +$1.89K | ﹤0.01% | 4597 |
|
|
2019
Q4 | $89K | Buy |
+2,336
| New | +$58.7K | ﹤0.01% | 5148 |
|
Other funds holding IGMS
Royal Bank of Canada's IGMS Position: Q3 2025 in Review
Royal Bank of Canada sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 40,728 shares — an estimated $45K sold.
Royal Bank of Canada first reported a position in IGMS in Q4 2019 and held it in 23 quarters. The position peaked at $2.38M in Q2 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Royal Bank of Canada reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Royal Bank of Canada sold 40,728 IGM Biosciences shares in Q3 2025, an estimated $45K.
- Royal Bank of Canada first reported a position in IGM Biosciences in Q4 2019 and held it in 23 quarters.
- Royal Bank of Canada's IGM Biosciences position peaked at $2.38M in Q2 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.